Physician profile
Galen E Howard
NPI 1558483552
$8,782.05
in general payments reported to CMS, 2019-2025
44 companies · $2,351 in 2025
The $2,351 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $298 · 2021: $575 · 2022: $1,515 · 2023: $1,871 · 2024: $1,651 · 2025: $2,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,642 · Education: $231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,641.73 |
| Education | $231.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,123.11 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $830.95 | 2019-2025 | Lithovue, General - Erectile Dysfunction, Moses 550 Dfl |
| Janssen Biotech, INC. | $672.45 | 2021-2025 | Erleada, Akeega, Balversa |
| Accord Healthcare, INC. | $655.92 | 2022-2025 | |
| Pfizer INC. | $589.86 | 2020-2025 | |
| Axonics, INC. | $555.03 | 2020-2024 | Axonics, Bulkamid |
| Bayer Healthcare Pharmaceuticals INC. | $553.31 | 2020-2025 | |
| Dendreon Pharmaceuticals LLC | $467.01 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $427.10 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $300.60 | 2024-2025 | Aquabeam System |
| Antares Pharma, INC. | $286.40 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Myovant Sciences INC. | $231.53 | 2021-2022 | |
| Urogen Pharma, INC. | $220.49 | 2021-2025 | Jelmyto |
| 180 Medical, INC. | $205.53 | 2019-2023 | Gentlecath |
| Ferring Pharmaceuticals INC. | $133.53 | 2024-2025 | Adstiladrin |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $109.19 | 2023-2025 | Trelstar, Tlando |
| Coloplast Corp | $108.96 | 2021-2024 | Speedicath, Luja Coude |
| Merck Sharp & Dohme LLC | $93.80 | 2021-2025 | Keytruda, Keytruda Qlex |
| Abbvie INC. | $87.17 | 2019-2024 | |
| Biotissue Holdings INC. | $86.41 | 2022-2023 | |
| Progenics Pharmaceuticals, INC. | $86.15 | 2022-2025 | Pylarify |
| Immunitybio, INC. | $75.72 | 2025 | |
| Innovation Technologies INC | $65.58 | 2022-2024 | Irrisept |
| Amgen INC. | $63.47 | 2023-2024 | Xgeva, Prolia, Evenity |
| Bk Medical Holding Company INC. | $59.03 | 2023 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Cook Medical LLC | $58.50 | 2020-2025 | Resonance |
| Endo Pharmaceuticals INC. | $58.10 | 2022-2023 | Xiaflex, Aveed |
| Olympus America INC. | $54.16 | 2024-2025 | Itind System, Soltive |
| Azurity Pharmaceuticals, INC. | $48.80 | 2025 | Azmiro |
| Valencia Technologies Corporation | $48.65 | 2025 | Ecoin Device Kit |
| Tolmar, INC. | $47.87 | 2023-2025 | Jatenzo, Eligard |
| Endo USA, INC. | $43.10 | 2024-2025 | Xiaflex, Aveed |
| Civco Medical Instruments | $42.21 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $42.04 | 2022-2023 | Lynparza |
| Neotract INC. | $39.06 | 2019 | |
| Tempus Ai, INC | $29.52 | 2024 | |
| Medtronic USA, INC. | $29.18 | 2019-2020 | |
| Teleflex LLC | $29.04 | 2022 | |
| Laborie Medical Technologies Corp. | $27.84 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Pacira Pharmaceuticals Incorporated | $27.02 | 2024 | Iovera, Zilretta, Exparel |
| Telix Pharmaceuticals | $20.03 | 2023 | Illuccix |
| Medtronic, INC. | $18.88 | 2024 | Interstim |
| Blue Earth Diagnostics | $16.43 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.32 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Galen Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.